Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.
about
Oncolytic Sendai virus-based virotherapy for cancer: recent advancesCytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene.Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune PathwaysVirosome presents multimodel cancer therapy without viral replication.
P2860
Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Immunogene therapy using immun ...... ts in murine malignant glioma.
@en
Immunogene therapy using immun ...... ts in murine malignant glioma.
@nl
type
label
Immunogene therapy using immun ...... ts in murine malignant glioma.
@en
Immunogene therapy using immun ...... ts in murine malignant glioma.
@nl
prefLabel
Immunogene therapy using immun ...... ts in murine malignant glioma.
@en
Immunogene therapy using immun ...... ts in murine malignant glioma.
@nl
P2093
P2860
P1476
Immunogene therapy using immun ...... ts in murine malignant glioma.
@en
P2093
Akira Matsumura
Keisuke Nimura
Masahide Matsuda
Takashi Shimbo
Tetsuya Yamamoto
Yasufumi Kaneda
P2860
P2888
P356
10.1007/S11060-010-0355-X
P577
2010-08-22T00:00:00Z
P6179
1014307743